Genetic Origin of Lipid Disorders
Sponsor: CIGENE, Agricultural University of Norway, Aas, Norway
Listed as NCT00277121, this observational or N/A phase trial focuses on Lipid Disorder and remains ongoing. Sponsored by CIGENE, Agricultural University of Norway, Aas, Norway, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Apr 2018 — Jan 2021 [monthly]
Unknown Status
Phase: PHASE1 → None
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status PHASE1
First recorded
Jan 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CIGENE, Agricultural University of Norway, Aas, Norway
- Hormone Laboratory, Aker University Hospital, Oslo, Norway
- Lipid Clinic, The National Hospital, Oslo, Norway
- Norwegian Institute of Public Health
- Research Institute of Internal Medicine, The National Hospital, Oslo, Norway
- Ullevaal University Hospital
- University of Oslo
For direct contact, visit the study record on ClinicalTrials.gov .